Adrenomedullin and diabetes mellitus.
Adrenomedullin (AM) is a novel 52 amino acid peptide hormone, originally isolated from human pheochromocytoma. AM acts as a local autocrine and/or paracrine vasoactive hormone and has vasodilator and blood pressure lowering properties. AM as a vasodilative molecule protects the vascular wall but its exact role is still uncertain. AM is considered to play an important endocrine role in various tissues in maintaining electrolyte and fluid homeostasis. Its plasma concentration in healthy conditions is low. In hypertension, chronic renal failure and congestive heart failure its plasma concentration increases in a parallel manner with the severity of the disease. It is assumed that this peptide plays an important role in physiological and pathological conditions compensating the effects of vasoconstrictive molecules. Investigations have proven that in diabetic angiopathies the levels and production of vasoconstrictive factors and AM are increased, while other relaxing substances such as nitric oxide (NO) are decreased. It is still uncertain whether the increased release of AM is a compensatory mechanism or a coincidental event. Although the precise role of AM in the pathogenesis of diabetic complications is still to be elucidated, the altered concentration of AM in diabetes could indicate a certain interaction between AM induction and vascular function. Hence, the induction of vascular AM can be a new target of therapeutic approach to diabetic complications.
Ruzicska
E
E
2nd Department of Medicine, Semmelweis University, Budapest, Hungary. ruzeva@bel2.sote.hu
Toth
M
M
Tulassay
Z
Z
Somogyi
A
A
D053607:Adrenomedullin; D000959:Antihypertensive Agents; D003920:Diabetes Mellitus; D003922:Diabetes Mellitus, Type 1 / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood; D006801:Humans; D010455:Peptides / Q000097:blood / Q000737:chemistry / Q000235:genetics / Q000502:physiology; D010673:Pheochromocytoma / Q000737:chemistry; D058265:Receptors, Adrenomedullin; D018000:Receptors, Peptide; D015290:Second Messenger Systems; D014665:Vasodilator Agents
D000959:Antihypertensive Agents; D010455:Peptides; D058265:Receptors, Adrenomedullin; D018000:Receptors, Peptide; D014665:Vasodilator Agents; D053607:Adrenomedullin